Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
National high priority program funds two projects to better understand how coronavirus interacts with proteins in human cells. Two members of the University of Rochester’s Department of Biology have received expedited funding awards from the National Science Foundation (NSF) to study biological processes involved in COVID-19. As labs reopen across
The city of Rochester and Monroe County have partnered with Common Ground Health to roll out ROC COVID, an online symptom tracker for community residents. Developed by scientists and information technology staff at the University of Rochester Medical Center and Rochester Regional Health, the health screening tool may help prevent
The University of Rochester Medical Center has been participating in a clinical trial testing the safety and efficacy of the antiviral drug remdesivir. According to preliminary results released by the National Institutes of Health, the drug is now showing promise in treating adults diagnosed with COVID-19. The study is led by Ann Falsey, a professor in
Given the changing circumstances due to the Covid-19 pandemic, URVentures has decided to cancel the Spring 2020 round of the Technology Development Fund. Please direct any questions to the Fund’s Director. Omar Bakht Fund Director Omar_Bakht@urmc.rochester.edu